Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.
暂无分享,去创建一个
A. Burks | H. Sampson | B. Vickery | M. Dorsey | M. Erlewyn-Lajeunesse | Julie Wang | J. Hourihane | D. Fleischer | P. Turner | K. Kloepfer | M. Greenhawt | A. Deschildre | D. Campbell | S. Sindher | T. Eiwegger | L. Schneider | K. Perrett | J. Peake | P. Arkwright | T. Green | E. Chan | J. Lieberman | Edwin H. Kim | J. Pongracic | R. Robison | C. Vogelberg | Nicola Jay | S. Anvari | C. Ciaccio | P. Bégin | L. Giovannini-Chami | W. Pfützner | K. Blumchen | L. Ford | G. Sanders | H. Sharma | G. Lezmi | P. Varshney | B. Wainstein | J. Lomas | N. Arends | D. Petroni | M. Makhija | T. Brown-Whitehorn | T. Bourrier | A. Divaret‐Chauveau | P. Quinn | L. Kerns | R. Wood | S. Leonard | G. du Toit | S. Dorris | M. Garcia-Lloret | M. O'Sullivan | A. Peillon | T. Bois | S. Jones | Christopher P. Parrish | Julia E M Upton | Christopher P Parrish | Katherine L. Tuttle | K. Bee | Deborah Albright | Heather Cassell | Juan Trujillo | Rihab Rouissi | Henry T Bahnson | J. Upton | H. Bahnson
[1] M. Greenhawt,et al. The Impact of Allergy Specialty Care on Healthcare Utilization Among Peanut Allergy Children in the United States. , 2022, The journal of allergy and clinical immunology. In practice.
[2] A. Lowe,et al. The natural history of peanut and egg allergy in children up to age 6 years in the HealthNuts population-based longitudinal study. , 2022, The Journal of allergy and clinical immunology.
[3] J. Baumert,et al. Peanut Cross-contamination in Randomly Selected Baked Goods. , 2022, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[4] Joanne P Yeung,et al. Real-world peanut OIT in infants may be safer than non-infant preschool OIT, and equally effective. , 2021, The journal of allergy and clinical immunology. In practice.
[5] William H. Yang,et al. Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results. , 2021, The journal of allergy and clinical immunology. In practice.
[6] A. Muraro,et al. Peanut‐induced anaphylaxis in children and adolescents: Data from the European Anaphylaxis Registry , 2020, Allergy.
[7] William H. Yang,et al. Long-Term, Open-Label Extension Study of the Efficacy and Safety of Epicutaneous Immunotherapy for Peanut Allergy in Children: PEOPLE 3-Year Results. , 2020, The Journal of allergy and clinical immunology.
[8] C. Dant,et al. Food Allergy from Infancy Through Adulthood. , 2020, The journal of allergy and clinical immunology. In practice.
[9] Todor A Popov,et al. Prevalence of Food Sensitization and Food Allergy in Children across Europe. , 2020, The journal of allergy and clinical immunology. In practice.
[10] B. Remington,et al. Risk Reduction in Peanut Immunotherapy. , 2020, Immunology and allergy clinics of North America.
[11] Douglas H. Jones,et al. Review Article: Unmet needs of children with peanut allergy: aligning the risks and the evidence. , 2020, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[12] M. Greenhawt,et al. Commercial Claims Costs Related to Healthcare Resource Use Associated With a Diagnosis of Peanut Allergy. , 2020, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[13] William H. Yang,et al. Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial , 2019, JAMA.
[14] K. Nadeau,et al. Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in Young Children: 749 , 2019, Journal of Allergy and Clinical Immunology.
[15] K. Nadeau,et al. The Public Health Impact of Parent-Reported Childhood Food Allergies in the United States , 2018, Pediatrics.
[16] J. Trainor,et al. Food-induced anaphylaxis in infants and children. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[17] D. Matlock,et al. Understanding caregiver goals, benefits, and acceptable risks of peanut allergy therapies. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[18] N. Shah,et al. National trends in emergency department visits and hospitalizations for food‐induced anaphylaxis in US children , 2018, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[19] T. Dwyer,et al. Food allergy and gastrointestinal disease The prevalence of food allergy and other allergic diseases in early childhood in a population-based study : HealthNuts age 4-year follow-up , 2022 .
[20] A. DunnGalvin,et al. Quality of life in childhood, adolescence and adult food allergy: Patient and parent perspectives , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[21] B. Vickery,et al. Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy , 2017, The Journal of allergy and clinical immunology.
[22] James T.C. Li,et al. Prospective Validation of the NIAID/FAAN Criteria for Emergency Department Diagnosis of Anaphylaxis. , 2016, The journal of allergy and clinical immunology. In practice.
[23] O. Bruyère,et al. Peanut‐allergic patients in the MIRABEL survey: characteristics, allergists’ dietary advice and lessons from real life , 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[24] M. Ben-Shoshan,et al. Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy , 2015, Clinical and Translational Allergy.
[25] A. Sheikh,et al. Prevalence of common food allergies in Europe: a systematic review and meta‐analysis , 2014, Allergy.
[26] Kirsten Beyer,et al. Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report. , 2012, The Journal of allergy and clinical immunology.
[27] Anne Muñoz-Furlong,et al. Further fatalities caused by anaphylactic reactions to food, 2001-2006. , 2007, The Journal of allergy and clinical immunology.
[28] C. Akdis,et al. Treatment for food allergy , 2018, The Journal of allergy and clinical immunology.
[29] J. Fine,et al. Early oral immunotherapy in peanut‐allergic preschool children is safe and highly effective , 2017, The Journal of allergy and clinical immunology.
[30] M. Goldberg,et al. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions. , 2014, The journal of allergy and clinical immunology. In practice.